Table 1.
Vaccine | Age Group (y) | 2007, % | 2008, % | 2009, % | 2010, % | 2011, % | 2012, % | 2013, % | 2014, % | 2015, % |
---|---|---|---|---|---|---|---|---|---|---|
PN | 19-49 | 32.3 | 24.9 | 17.5 | 18.5 | 20.1 | 20.0 | |||
18-64 | 19.4 | 16.6 | 17.4 | 18.3 | 20.0 | |||||
≥65 | 65.6 | 60.0 | 60.6 | 59.5 | 62.3 | 59.9 | ||||
FLU | ≥19 | 33.6 | 40.4 | 40.5 | 38.8 | 41.5 | 42.2 | 43.6 | ||
19-49 | 30.5 | 28.6 | 31.1 | 32.3 | ||||||
19-49 HR | 37.3 | 30.0 | 33.4 | 39.0 | 36.8 | 39.8 | ||||
19-49 non-HR | 17.4 | 19.7 | ||||||||
50-64 total | 38.7 | 44.5 | 42.7 | 45.1 | 45.3 | |||||
50-64 HR | 48.8 | 51.5 | ||||||||
50-64 non-HR | 34.4 | 34.2 | ||||||||
≥65 | 66.6 | 65.6 | 66.6 | 64.9 | 66.2 | 65.0 | ||||
18-64 | 24.9 | 34.8 | 33.1 | 35.7 | 36.7 | |||||
18-64 HR | 38.6 | 46.7 | 45.2 | 47.0 | 46.3 | |||||
18-64 non-HR | 33.9 | |||||||||
HAV total | 19-49 | 12.1 | 8.8 | 9.8 | 10.7 | 12.5 | 12.2 | |||
HAV HR | 14.6 | |||||||||
HAV CLD | 19.7 | 17.1 | ||||||||
HBV total | 19-49 | 23.4 | 35.9 | 35.3 | ||||||
HBV HR | 31.6 | 41.8 | 42.0 | |||||||
HBV non-HR | 33.8 | 33.7 | 33.1 | |||||||
HBV CLD | ||||||||||
HBV | ≥ 65 | |||||||||
HZ | ≥ 60 | 1.9 | 6.7 | 10.0 | 14.4 | 15.8 | 20.1 |
aCLD = chronic liver disease; FLU = influenza; HAV = hepatitis A virus; HBV = hepatitis B virus; HR = high-risk people; HZ = herpes zoster; PN = pneumococcal pneumonia.